Displaying 1 - 1 of 1
| Active Ingredient | BOSENTAN |
| Therapeutic Class | VASODILATING AGENTS MISCELLANEOUS |
| Indications | Pulmonary Hypertension. |
| Caution | Contra-indicated in patients with moderate to severe hepatic impairment, headache, nasopharyngitis, flushing, oedema, hypotension, dizziness, palpitations, gastrointestinal disturbances, pruritus More ... |
| Dose Range | 12 years and older: Initially 62.5 mg twice daily, increased after 4 weeks to a maintenance dose of 125 mg twice daily. Patients with low body weight (below 40kg) 62.5 mg twice daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |